ANI Pharmaceuticals, Inc. (BST:BSFA)

Market Cap	1.54B
Revenue (ttm)	704.75M
Net Income (ttm)	29.10M
Shares Out	n/a
EPS (ttm)	1.43
PE Ratio	52.77
Forward PE	10.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	32
Open	71.50
Previous Close	72.50
Day's Range	69.00 - 73.50
52-Week Range	49.60 - 84.00
Beta	n/a
RSI	55.76
Earnings Date	Mar 4, 2026

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group pu...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 897
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: BSFA

Financial Performance

Financial numbers in USD